April 23, 2012 |
Oncologist Ubaldo Martinez doesn't have enough time to address all the special needs of the growing number of elderly cancer victims who seek his help, even though he spends 90 minutes with patients the first time and 30 during subsequent visits. It's all he can do to explain their disease and its treatments to them, but so many other things can affect how they'll do. How many drugs are they taking? Are they frail? Or robust enough to race their grandkids up a hill? Do they have dementia?
November 10, 2011 |
Robert D. Harwick, 88, a former chief of surgical oncology at Temple University Hospital, died of a myocardial infarction on Friday, Oct. 14, at his home in Wyncote. Born in Utica, N.Y., he studied at Cornell University from 1941 to 1943, in an accelerated World War II program for premedical students, before entering Cornell's medical school. Though a Cornell underclassman, he was captain of the golf team and was good enough, daughter Elizabeth Green said in an interview Tuesday, that "he had to choose between a pro golf career and medicine.
July 11, 2011 |
Fox Chase Cancer Center and the Temple University Health System, two institutions with storied pasts and potentially turbulent futures, are looking into a possible affiliation that health-care experts say could make sense for each of them. While confirming that they had signed a letter of intent "to explore a potential affiliation," neither one would discuss the possibilities. In theory, those could range from outright merger to nothing at all. The nonprofit institutions also could simply formalize what is already shared: Temple's bone-marrow transplant program serves Fox Chase patients, university medical residents do oncology training there, and several services are shared by Fox Chase and Temple's Jeanes Hospital, which sit on opposite sides of Burholme Park in Northeast Philadelphia.
July 30, 2010 |
Ladawna Leeth of Eastampton is living proof that cancer can, in some ways, change a person's life for the better. Despite the treatment and tribulations that accompany a diagnosis, cancer tends to put patients' priorities into perspective and refine their life goals, said Leeth, 46, the newly appointed director of the Cancer Institute of New Jersey Hamilton, an adjunct to the Robert Wood Johnson University Hospital campus in Mercer County. Leeth, a 22-year thyroid cancer survivor, draws on her experience to create the best treatment plan for CINJ Hamilton's patients.
June 26, 2010 |
Susane J. Zamitis, 65, of Oaklyn, a nursing instructor who taught for more than 40 years and wrote for education publications, died Sunday, June 20, at her home. She had been suffering from liver cancer. Though she loved helping people, Mrs. Zamitis did not just want to be a nurse. "Her passion was teaching," her son Robbert said. Year after year, she trained students in the classroom and during clinical sessions to help improve the quality of nursing care, said a former colleague, Debra DeVoe of Cherry Hill.
March 21, 2008 |
Cephalon Inc. received clearance from regulators yesterday to begin selling Treanda as a treatment for a rare form of leukemia. The medicine will be a new option for about 15,000 people in the United States diagnosed annually with the slow-progressing form of leukemia known as chronic lymphocytic leukemia, or CLL. The Frazer, Pa., biotech company said it hoped to make Treanda the foundation for a growing oncology business. "We are extremely excited about the future of our oncology business, particularly Treanda, which is a much-needed alternative for patients," chairman and chief executive officer Frank Baldino Jr. said after word of the approval by the Food and Drug Administration.
September 21, 2007 |
John E. Biaglow, 70, of Sicklerville, professor of radiation oncology at the University of Pennsylvania School of Medicine, died of a heart attack last Friday at the Hospital of the University of Pennsylvania. Dr. Biaglow had a reputation as a groundbreaking cancer biochemist when he joined the department of radiation oncology at Penn in 1984 and was later director until 2005. From 1987 to 1996, he directed the tumor metabolism program at Penn's Abramson Cancer Center. He published 130 articles in scientific journals.
January 17, 2003 |
Johnson & Johnson said yesterday that it would acquire 3-Dimensional Pharmaceuticals Inc., of Yardley, in a cash deal valued at $88 million. The pharmaceutical and health-care products giant will pay $5.74 for each 3-Dimensional share, which closed at $5.64 yesterday on the Nasdaq stock market. The announcement sent the small company's shares soaring $2.61, or 86.1 percent, at yesterday's close. 3-Dimensional Pharmaceuticals has drugs in early-stage research for treating cardiovascular disorders, oncology and inflammation.
November 8, 1998 |
Fox Chase Cancer Center and Temple University are combining their cancer treatment programs in an academic partnership to be announced tomorrow. The partnership gives Fox Chase easy access to non-cancer specialists, while Temple gains an affiliation with one of the nation's premier oncology programs. Neither institution adopts financial risk in the deal. "We look at this as an extension of our clinical and research mission to improve patient care and research," said Robert F. Ozols, Fox Chase senior vice president.
October 20, 1998 |
Delaware County Memorial Hospital in Drexel Hill has opened its $4.5 million radiation oncology department, bringing cancer treatment and support services together on the first floor of the adjacent medical office building. The department has a new dual-energy linear accelerator for radiation therapy and a computerized system for planning individual treatment, said spokeswoman Karen Babiak. The center's decor and easy access also make it more comfortable for visits, she said.